Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Operating Income: 2017-2024

Historic Operating Income for DiaMedica Therapeutics (DMAC) over the last 8 years, with Dec 2024 value amounting to -$26.7 million.

  • DiaMedica Therapeutics' Operating Income fell 30.85% to -$2.8 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$11.6 million, marking a year-over-year decrease of 71.49%. This contributed to the annual value of -$26.7 million for FY2024, which is 25.46% down from last year.
  • DiaMedica Therapeutics' Operating Income amounted to -$26.7 million in FY2024, which was down 25.46% from -$21.3 million recorded in FY2023.
  • DiaMedica Therapeutics' 5-year Operating Income high stood at -$12.7 million for FY2020, and its period low was -$26.7 million during FY2024.
  • In the last 3 years, DiaMedica Therapeutics' Operating Income had a median value of -$21.3 million in 2023 and averaged -$20.6 million.
  • Data for DiaMedica Therapeutics' Operating Income shows a maximum YoY tumbled of 51.90% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows DiaMedica Therapeutics' Operating Income stood at -$12.7 million in 2020, then decreased by 7.46% to -$13.6 million in 2021, then declined by 2.60% to -$14.0 million in 2022, then plummeted by 51.90% to -$21.3 million in 2023, then fell by 25.46% to -$26.7 million in 2024.